Maps (MAPS) Investor Presentation summary
Event summary combining transcript, slides, and related documents.
Investor Presentation summary
15 Jul, 2025Business overview and evolution
Focus on innovative custom software, advanced data analytics, and digital transformation across healthcare, energy, and ESG sectors.
Growth driven by acquisitions, product innovation, and expansion into fast-growing markets.
Transitioned from custom projects to a product-based business model, with a strong emphasis on recurring revenues.
IPO on Borsa Italiana provided recognition and growth momentum.
Strategic acquisitions, such as Ellysse, enhance capabilities in virtual assistance and omnichannel solutions.
Financial performance and key metrics
2024 revenues reached €29.8M, up 8% from 2023, with EBITDA at €7.4M, a 47% increase.
EBITDA margin improved to 24.7% from 18.1% in 2023.
Net financial position improved significantly, halving debt to €7.0M.
87% of revenues in 2024 came from proprietary products, with 41% from recurring fees.
Operating costs remained stable, while gross and EBITDA margins increased year-over-year.
Business unit performance and market positioning
Healthcare unit led with €18.5M in revenues and a 29% EBITDA margin, maintaining leadership in patient experience solutions.
Energy and ESG units showed double-digit revenue growth, with strong market positioning in energy community management software.
Healthcare solutions adopted by 20% of public hospitals and all major private groups in Italy.
Energy business benefits from a rapidly expanding market, with €5.7B allocated to energy communities and €12.7B to efficiency initiatives.
Ellysse acquisition strengthens non-healthcare and healthcare virtual assistance offerings.
Latest events from Maps
- Healthcare-led product growth and Ellysse acquisition drive strategy amid margin pressure.MAPS
H1 202524 Sep 2025 - Digital transformation in healthcare and energy drives robust growth and strong future outlook.MAPS
Investor Presentation15 Jul 2025 - Record profitability and product-driven growth position the group for further expansion.MAPS
Investor Presentation15 Jul 2025 - Profitability and cash flow surged in 1H 2024, driven by double-digit revenue growth.MAPS
H1 202415 Jul 2025 - Record profitability and cash flow growth driven by scalable products and healthcare strength.MAPS
H2 202415 Jul 2025